Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Technologies Announces Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
SEATTLE , Aug. 13, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the underwriters of its previously announced underwritten public offering have exercised their
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Second Quarter of 2018
SEATTLE , Aug. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2018. Second Quarter Financial Highlights Total product
View HTML
Toggle Summary NanoString Expands Centers of Excellence Program and Initiates Early Access Launch for Digital Spatial Profiling
Two Leading Centers to Explore Spatial Genomics Synergies with Single-Cell Biology, Next-Generation Sequencing, and Advanced Imaging Technologies Announces Early Access Launch for Five Additional Beta Instruments SEATTLE , Aug. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString Technologies Announces Closing of Public Offering of 4,000,000 Shares of Common Stock
SEATTLE , July 23, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 4,000,000 shares of its
View HTML
Toggle Summary NanoString Technologies Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
SEATTLE , July 17, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at a price
View HTML
Toggle Summary NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE , July 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it intends to offer and sell, subject to market and other conditions, $50 million of its
View HTML
Toggle Summary NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018
- Second Quarter Product and Service Revenue Exceeds High End of Company Guidance - SEATTLE , July 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary
View HTML
Toggle Summary NanoString to Release Second Quarter 2018 Financial Results and Host Conference Call on Tuesday, August 7, 2018
SEATTLE , July 09, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2018 financial results after the close of trading on
View HTML
Toggle Summary NanoString Establishes Netherlands Cancer Institute as a Center of Excellence for Digital Spatial Profiling
First Center of Excellence to Focus on Clinical Research and Biomarker Development SEATTLE , June 18, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the
View HTML
Toggle Summary NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery
NanoString’s PanCancer IO 360 panel will be used for characterization of immune activity and development of potentially predictive gene signatures in NCI-sponsored trials SEATTLE , June 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for
View HTML